KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
KLDO
Delisted
KLDO was delisted on the 14th of April, 2022.
63 hedge funds and large institutions have $55.1M invested in Kaleido Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $80.8M → $55.1M (-$25.7M)
52% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 23
Holders
63
Holding in Top 10
1
Calls
$343K
Puts
$1K
Top Buyers
| 1 | +$78.2K | |
| 2 | +$64.1K | |
| 3 | +$19.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.62K |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.31K |
Top Sellers
| 1 | -$275K | |
| 2 | -$109K | |
| 3 | -$80.3K | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$51.7K |
| 5 |
E
Ergoteles
New York
|
-$47K |